Guj. Inject(Ker)

Why is Gujarat Inject (Kerala) Ltd falling/rising?

As of 01-Sep, Gujarat Inject (Kerala) Ltd's stock price is at 10.94, down 0.55%, having fallen for four consecutive days with a total decline of 12.54%. Despite recent short-term losses, the stock has gained 205.59% year-to-date and shows increased investor interest, suggesting potential for recovery.

As of 01-Sep, Gujarat Inject (Kerala) Ltd's stock price is currently at 10.94, reflecting a decrease of 0.06 or 0.55%. The stock has been experiencing a downward trend, having fallen for the last four consecutive days, resulting in a total decline of 12.54% during this period. <BR><BR>In terms of performance relative to the benchmark, the stock has shown a significant increase over longer periods, with a year-to-date gain of 205.59% and a remarkable 428.50% increase over the past year. However, in the short term, specifically over the past week, the stock has decreased by 8.30%, while the Sensex has only fallen by 0.92%. <BR><BR>Despite the recent price drop, there has been a rise in investor participation, as evidenced by a 36.32% increase in delivery volume on August 31 compared to the five-day average. This suggests that while the stock is currently falling, there is still interest from investors, which may indicate potential for recovery in the future. <BR><BR>Overall, the combination of recent consecutive declines, short-term performance lagging behind the benchmark, and the stock being lower than several moving averages contribute to the current downward movement in Gujarat Inject (Kerala) Ltd's stock price.

Which are the latest news on Guj. Inject(Ker)?

Who are in the management team of Guj. Inject(Ker)?

The management team of Guj. Inject(Ker) consists of Murli Shivshankaran Nair (Whole Time Director & CFO), Reena Mahatma (Director), and independent directors Narayansinh Padudansinh Chauhan and Gautam Keshavlal Chauhan.

The management team of Guj. Inject(Ker) includes the following individuals:<BR><BR>1. **Murli Shivshankaran Nair** - Whole Time Director & CFO<BR>2. **Reena Mahatma** - Director<BR>3. **Narayansinh Padudansinh Chauhan** - Independent Director<BR>4. **Gautam Keshavlal Chauhan** - Independent Director<BR><BR>If you need more details about their roles or the company's activities, feel free to ask!

What does Guj. Inject(Ker) do?

Gujarat Inject (Kerala) Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology sector, incorporated in 1991, with recent quarterly net sales of 12 Cr and a net profit of 1 Cr as of June 2026. The company has no debt and a market cap of INR 165 Cr.

Overview:<BR>Gujarat Inject (Kerala) Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>The company was incorporated in January 1991 and initially promoted by Gujarat Inject Limited and the Kerala State Industrial Development Corporation. There were no operations during the first half of the year 1998-99, but it entered into a manufacturing contract with a reputed I.V. Fluid manufacturer in the second half of 1999. The latest reported quarter for sales and profit is June 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 12 Cr (Quarterly Results - Jun 2026)<BR>- Net Profit: 1 Cr (Quarterly Results - Jun 2026)<BR>- Market Cap: INR 165 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- Industry P/E: 37<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.00<BR>- Return on Equity: 0.00%<BR>- Price to Book: 0.00<BR><BR>Contact Details:<BR>Address: Bldg No XVII/1103 Kanjikode, Sarayu Arcade Satrapadi Palakkad Kerala : 678621<BR>Website: http://www.gujaratinject.com

Who are the peers of the Guj. Inject(Ker)?

Peers of Guj. Inject(Ker) include Brooks Lab., CCME Global, Syschem (India), Achyut Healthcar, Smruthi Organic, Panch.Organics, Auro Labs., and Sat Kartar Life. Guj. Inject(Ker) leads with a 406.91% 1-year return, significantly outperforming its peers, while others show varying management risks and growth ratings.

Peers: The peers of Guj. Inject(Ker) are Brooks Lab., CCME Global, Syschem (India), Achyut Healthcar, Smruthi Organic, Panch.Organics, Auro Labs., and Sat Kartar Life.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sat Kartar Life, while Average management risk is found at Smruthi Organic, Panch.Organics, and Auro Labs., and the rest. Below Average management risk is noted at Brooks Lab., CCME Global, Syschem (India), Achyut Healthcar, and the rest. For Growth, Excellent growth is seen at Sat Kartar Life, Good growth at Syschem (India), CCME Global, and Achyut Healthcar, Average growth at Achyut Healthcar, and the rest, while Below Average growth is noted at Brooks Lab., Smruthi Organic, and Auro Labs. Capital Structure ratings show Excellent at Panch.Organics, Good at CCME Global, Syschem (India), Achyut Healthcar, and Smruthi Organic, and Below Average at Brooks Lab. and Auro Labs.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Guj. Inject(Ker) at 406.91%, while the lowest is CCME Global with an unspecified return. Guj. Inject(Ker)'s return significantly exceeds all peers. Additionally, Syschem (India), Panch.Organics, and Auro Labs. have negative six-month returns.

How big is Guj. Inject(Ker)?

As of 31st August, Gujarat Inject (Kerala) Ltd has a market capitalization of 165.00 Cr, with recent Net Sales of 46.36 Cr and a Net Profit of 3.00 Cr. The balance sheet for March 2025 shows Shareholder's Funds of 10.01 Cr and Total Assets of 11.95 Cr.

As of 31st August, Gujarat Inject (Kerala) Ltd has a market capitalization of 165.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Gujarat Inject (Kerala) Ltd reported Net Sales of 46.36 Cr and a Net Profit of 3.00 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, showing Shareholder's Funds of 10.01 Cr and Total Assets of 11.95 Cr.

When is the next results date for Gujarat Inject (Kerala) Ltd?

The next results date for Gujarat Inject (Kerala) Ltd is 14 February 2026.

The next results date for Gujarat Inject (Kerala) Ltd is scheduled for 14 February 2026.

How has been the historical performance of Guj. Inject(Ker)?

Guj. Inject(Ker) has shown significant growth from March 2022 to March 2025, with net sales increasing from 0.02 crore to 19.05 crore and operating profit turning positive at 1.26 crore. The company also improved its profit before tax to 1.25 crore and earnings per share rose to 0.7, indicating strong revenue and profitability growth.

Answer:<BR>The historical performance of Guj. Inject(Ker) shows significant growth in net sales and profitability over the years, particularly from March 2022 to March 2025.<BR><BR>Breakdown:<BR>Guj. Inject(Ker) experienced a remarkable increase in net sales, rising from just 0.02 crore in March 2022 to 19.05 crore in March 2025. This growth is reflected in total operating income, which also surged from 0.02 crore in March 2022 to 19.05 crore in March 2025. The company's total expenditure, excluding depreciation, increased from 0.07 crore in March 2022 to 17.97 crore in March 2025, indicating a rise in operational costs alongside revenue growth. Operating profit, which was negative in earlier years, turned positive, reaching 1.26 crore in March 2025, with an operating profit margin of 5.67%. Profit before tax also improved significantly, from 0.00 crore in March 2022 to 1.25 crore in March 2025, leading to a profit after tax of 1.02 crore in the same period. The earnings per share (EPS) rose from 0.0 in March 2022 to 0.7 in March 2025, showcasing enhanced shareholder value. Overall, the financial data indicates a strong upward trend in both revenue and profitability for Guj. Inject(Ker) over the analyzed period.

Who are the top shareholders of the Guj. Inject(Ker)?

The top shareholders of Guj. Inject(Ker) are mainly individual investors, holding 83.95% of shares, with Jignesh Shivlal Makasana as the largest public shareholder at 11.95%. There are no institutional holdings or pledged promoter shares.

The top shareholders of Guj. Inject(Ker) are primarily individual investors, who hold a significant 83.95% of the shares. Among public shareholders, Jignesh Shivlal Makasana stands out with a holding of 11.95%. There are no institutional holdings from mutual funds or foreign institutional investors, and there are no pledged promoter holdings. The majority of the shares are held by non-institutional entities.

What is the technical trend for Guj. Inject(Ker)?

As of May 22, 2025, the technical outlook is mildly bullish, supported by daily moving averages and KST indicators, despite mixed signals from the Bollinger Bands and a bearish weekly MACD.

As of 22 May 2025, the technical trend has changed from sideways to mildly bullish. The daily moving averages indicate a bullish stance, while the weekly MACD shows a mildly bearish trend. The Bollinger Bands present a mixed view with a bearish signal on the weekly and a mildly bullish signal on the monthly. The KST is bullish on the weekly timeframe, supporting the mildly bullish outlook. However, the weekly Dow Theory indicates a bullish trend, while the monthly shows no trend. Overall, the current technical stance is mildly bullish, driven primarily by daily moving averages and KST indicators.

Has Guj. Inject(Ker) declared dividend?

No Dividend History Available